Leveraging immuno-fluorescence data to reduce pathologist annotation requirements in lung tumor segmentation using

Hatef Mehrabian1, Jens Brodbeck2, Peipei Lyu2

  • 1Non-Clinical Safety and Pathobiology, Gilead Sciences, Foster City, CA, USA. hatef.mehrabian@gilead.com.

Scientific Reports
|September 16, 2024
PubMed
Summary

Pre-training tumor segmentation models with cost-effective pan-cytokeratin (panCK) annotations significantly reduces the need for expensive pathologist annotations in non-small cell lung cancer (NSCLC) research. This approach achieves high accuracy while ensuring model generalizability across diverse H&E imaging data.

Related Concept Videos